SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Belldegrun Arie (Last) (First) (Middle) C/O ARNO THERAPEUTICS, INC. 200 ROUTE 31 NORTH, SUITE 104 (Street) FLEMINGTON NJ 08822 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Arno Therapeutics, Inc [ ARNI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 04/29/2013
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/29/2013		J(1)		20,000	A	$0.3	40,000	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust(2)
Common Stock	04/29/2013		J(3)		23,333	A	$0.3	174,285	I	Belldegrun Family Trust(4)
Common Stock	04/29/2013		J(5)		10,000	A	$0.3	147,619	I	MDRB Partnership, L.P.(6)
Common Stock	04/29/2013		J(7)		13,333	A	$0.3	26,666	I	Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan(8)
Common Stock								24,922	D
Common Stock								317,155	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust(9)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$2.42							(10)	03/31/2018	Common Stock	199,377		199,377	D
Stock Option (right to buy)	$1							(10)	09/29/2019	Common Stock	10,000		10,000	D
Stock Option (right to buy)	$1							(10)	09/09/2020	Common Stock	300,000		300,000	D
Stock Option (right to buy)	$1							(11)	11/05/2020	Common Stock	10,000		10,000	D
Class B Warrants (right to buy)	$0.5649							09/09/2010	09/09/2015	Common Stock	105,000		105,000	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust(9)
8% Senior Convertible Debentures	$0.3							11/26/2012	11/26/2015	Common Stock	1,000,000		1,000,000	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust(2)
Series A Warrants (right to buy)	$0.5							11/26/2012	11/26/2017	Common Stock	1,000,000		1,000,000	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust(2)
Series B Warrants	$0.3							11/26/2012	05/26/2014	Common Stock	1,000,000		1,000,000	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust(2)
Class B Warrants (right to buy)	$0.5649							09/09/2010	09/09/2015	Common Stock	52,500		52,500	I	Belldegrun Family Trust(4)
8% Senior Convertible Debentures	$0.3							11/26/2012	11/26/2015	Common Stock	1,166,667		1,166,667	I	Belldegrun Family Trust(4)
Series A Warrants (right to buy)	$0.5							11/26/2012	11/26/2017	Common Stock	1,166,667		1,166,667	I	Belldegrun Family Trust(4)
Series B Warrants (right to buy)	$0.3							11/26/2012	05/26/2014	Common Stock	1,166,667		1,166,667	I	Belldegrun Family Trust(4)
Class B Warrants (right to buy)	$0.5649							09/09/2010	09/09/2015	Common Stock	52,500		52,500	I	MDRB Partnership, L.P.(6)
8% Senior Convertible Debentures	$0.3							11/26/2012	11/26/2015	Common Stock	500,000		500,000	I	MDRB Partnership, L.P.(6)
Series A Warrants (right to buy)	$0.5							11/26/2012	11/26/2017	Common Stock	500,000		500,000	I	MDRB Partnership, L.P.(6)
Series B Warrants (right to buy)	$0.3							11/26/2012	05/26/2014	Common Stock	500,000		500,000	I	MDRB Partnership, L.P.(6)
8% Senior Convertible Debentures	$0.3							11/26/2012	11/26/2015	Common Stock	666,667		666,667	I	Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan(8)
Series A Warrants (right to buy)	$0.5							11/26/2012	11/26/2017	Common Stock	666,667		666,667	I	Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan(8)
Series B Warrants (right to buy)	$0.3							11/26/2012	05/26/2014	Common Stock	666,667		666,667	I	Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan(8)

Explanation of Responses:

1. Shares issued in lieu of cash payment of liquidated damages in the amount of $6,000, pursuant to the terms of a Registration Rights Agreement dated November 26, 2012 among the Issuer and the investors identified therein, as amended on March 25, 2013.

2. Although the Reporting Person is not a trustee of the Tampere Trust, the Reporting Person is a beneficiary of the Tampere Trust, and as such may be deemed to be the beneficial owner of the securities owned by the Tampere Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

3. Shares issued in lieu of cash payment of liquidated damages in the amount of $7,000, pursuant to the terms of a Registration Rights Agreement dated November 26, 2012 among the Issuer and the investors identified therein, as amended on March 25, 2013.

4. The Reporting Person is the trustee of the family trust that owns the securities. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

5. Shares issued in lieu of cash payment of liquidated damages in the amount of $3,000, pursuant to the terms of a Registration Rights Agreement dated November 26, 2012 among the Issuer and the investors identified therein, as amended on March 25, 2013.

6. The Reporting Person is the managing partner of the limited partnership that owns the securities. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

7. Shares issued in lieu of cash payment of liquidated damages in the amount of $4,000, pursuant to the terms of a Registration Rights Agreement dated November 26, 2012 among the Issuer and the investors identified therein, as amended on March 25, 2013.

8. The Reporting Person is the trustee of the profit sharing plan that owns the securities.

9. Although the Reporting Person is not a trustee of the BTL Trust, the Reporting Person is a beneficiary of the BTL Trust, and as such may be deemed to be the beneficial owner of the securities owned by the BTL Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

10. Currently exercisable.

11. Vests in three equal annual installments commencing 11/5/11.

Remarks:

	/s/ Christopher J. Melsha as Attorney-in-Fact for Arie S. Belldegrun pursuant to a Power of Attorney previously filed.	05/07/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.